{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:46:20Z","timestamp":1777898780421,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100018795","name":"Florida Academic Cancer Center Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Moffitt Cancer Center Center for Immunization and Infection Research in Cancer"},{"name":"National Cancer Institute","award":["P30-CA076292"],"award-info":[{"award-number":["P30-CA076292"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023043","name":"State of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CDRN-1501-26692"],"award-info":[{"award-number":["CDRN-1501-26692"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["4KB16"],"award-info":[{"award-number":["4KB16"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) screening rates are low in the United States and may be lower among populations experiencing social vulnerability. Little is known about these potential disparities. The current study examined HCV screening prevalence across time, spatial distribution, and social vulnerability among adults in Florida.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We used data on clinical encounters from the OneFlorida+ data repository to examine the prevalence of HCV screening among adult patients in Florida (N\u2009=\u20091 380 811) from August 1, 2015, through July 31, 2021, by birth cohort (1924-1944, 1945-1965, 1966-1985, and 1986-1997) and risk group (average vs high risk of HCV infection based on behavioral and medical factors). Among patients with a recorded 9-digit zip code (n\u2009=\u2009853 965), we conducted spatial analyses, and we used the Centers for Disease Control and Prevention\/Agency for Toxic Substances and Disease Registry Social Vulnerability Index (SVI) to examine screening disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The 1945-1965 birth cohort had the highest likelihood of HCV screening (7.9% among average-risk patients and 24.2% among high-risk patients); those in the 1924-1944 birth cohort had the lowest likelihood (2.0% among average-risk patients and 8.6% among high-risk patients). High-risk patients in almost every geographic area were more likely than average-risk patients to be screened. Screening prevalence was highest in north and northeastern Florida. Among all patients, screening tended to be most likely among those with the highest socioeconomic status and with either the least or most social vulnerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>HCV screening rates were low in Florida across all study years and birth cohorts. Spatial and SVI analyses revealed geographic disparities by region and social vulnerability groups. Interventions are needed to support HCV elimination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00333549251403385","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:27:03Z","timestamp":1768354023000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Hepatitis C Virus Antibody Testing Across Geography, Time, and Social Vulnerability Among Adults in Florida, 2015-2021"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5306-7020","authenticated-orcid":false,"given":"Shannon M.","family":"Christy","sequence":"first","affiliation":[{"name":"Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Buhlmann","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Kang","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Reich","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-2200","authenticated-orcid":false,"given":"Julie A.","family":"Rathwell","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9879-7235","authenticated-orcid":false,"given":"Monica L.","family":"Kasting","sequence":"additional","affiliation":[{"name":"Department of Public Health, Purdue University, West Lafayette, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T.","family":"Vadaparampil","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-8859","authenticated-orcid":false,"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"},{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA"},{"name":"Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"American Cancer Society. Liver cancer risk factors. Updated April 1 2019. Accessed August 8 2023. https:\/\/www.cancer.org\/cancer\/types\/liver-cancer\/causes-risks-prevention\/risk-factors.html"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.52979"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30297"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27978"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2575"},{"key":"e_1_3_2_7_2","unstructured":"Centers for Disease Control and Prevention. Treatment of hepatitis C. 2023. Accessed October 7 2025. https:\/\/www.cdc.gov\/hepatitis-c\/treatment\/index.html"},{"key":"e_1_3_2_8_2","unstructured":"Centers for Disease Control and Prevention. Clinical screening and diagnosis for hepatitis C. January 31 2025. Accessed December 18 2024. https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/diagnosis-testing\/index.html"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad411"},{"key":"e_1_3_2_10_2","unstructured":"US Preventive Services Task Force. Final recommendation statement: hepatitis C virus infection in adolescents and adults: screening. March 2 2020. Accessed December 18 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hepatitis-c-screening"},{"issue":"4","key":"e_1_3_2_11_2","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith BD","year":"2012","unstructured":"Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_12_2","unstructured":"Centers for Disease Control and Prevention. CDC vital signs: hepatitis C: testing Baby Boomers saves lives. May 2013. Accessed December 18 2024. https:\/\/www.cdc.gov\/vitalsigns\/pdf\/2013-05-vitalsigns.pdf"},{"issue":"19","key":"e_1_3_2_13_2","first-page":"1","volume":"47","author":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","year":"1998","unstructured":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.06.008"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13661"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix202"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7321a4"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549241260252"},{"key":"e_1_3_2_19_2","unstructured":"HepVu.org. Estimated number of people living with hepatitis C 2013-2016. No date. Accessed December 18 2024. https:\/\/map.hepvu.org\/hepc-prevalence\/state\/case\/none\/none\/florida?geoContext=national"},{"key":"e_1_3_2_20_2","unstructured":"University of Florida. OneFlorida+ Clinical Research Network. 2024. Accessed December 18 2024. https:\/\/onefl.net"},{"key":"e_1_3_2_21_2","unstructured":"Centers for Disease Control and Prevention. Social Vulnerability Index. July 22 2024. Accessed December 18 2024. https:\/\/www.atsdr.cdc.gov\/place-health\/php\/svi\/index.html"},{"key":"e_1_3_2_22_2","unstructured":"Centers for Disease Control and Prevention. International Classification of Diseases Ninth Revision Clinical Modification (ICD-9-CM). Last reviewed November 3 2021. Accessed October 7 2025. https:\/\/archive.cdc.gov\/www_cdc_gov\/nchs\/icd\/icd9cm.htm"},{"key":"e_1_3_2_23_2","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics. Classification of Diseases Functioning and Disability. ICD-10-CM. June 7 2024. Accessed October 7 2025. https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.2202\/1547-7355.1792"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279972"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11020209"},{"key":"e_1_3_2_27_2","volume-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine Committee on Quality of Health Care in America","year":"2001","unstructured":"Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press; 2001."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0855"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.03.007"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2247"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102602"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.102011"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23561"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/15248399231169924"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-018-0545-6"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.180671"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.06.016"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106040"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2021.652672"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7132e1"},{"key":"e_1_3_2_41_2","unstructured":"US Department of Health and Human Services. Healthy People 2030. Increase the proportion of people who no longer have hepatitis\u2014IID\u201114. 2021. Accessed July 24 2023. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/infectious-disease\/increase-proportion-people-who-no-longer-have-hepatitis-c-iid-14"},{"key":"e_1_3_2_42_2","unstructured":"US Department of Health and Human Services. Healthy People 2030. Reduce the rate of acute hepatitis C\u2014IID\u201112. 2021. Accessed July 24 2023. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/infectious-disease\/reduce-rate-acute-hepatitis-c-iid-12"},{"key":"e_1_3_2_43_2","unstructured":"US Department of Health and Human Services. Healthy People 2030. Reduce the rate of deaths with hepatitis C as a cause\u2014IID\u201116. 2021. Accessed July 24 2023. https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/infectious-disease\/reduce-rate-deaths-hepatitis-c-cause-iid-16"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549251403385","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00333549251403385","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549251403385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:40:49Z","timestamp":1777628449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00333549251403385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":42,"alternative-id":["10.1177\/00333549251403385"],"URL":"https:\/\/doi.org\/10.1177\/00333549251403385","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"article-number":"00333549251403385"}}